What is the ticker symbol for Entrada Therapeutics?

Entrada Therapeutics trades under the ticker TRDA on NASDAQ.

What sector does Entrada Therapeutics operate in?

Entrada Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze TRDA in a portfolio?

PortView shows TRDA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Entrada Therapeutics (TRDA) Stock Analysis

NASDAQHealthcareBiotechnology

$7.08+0.07%

1-year price historyRange $5.06 – $16.03

52-week range$7.08

$5.02$16.45

What Entrada Therapeutics does

Entrada Therapeutics, Inc. operates as a biotechnology enterprise dedicated to pioneering endosomal escape vehicle (EEV) therapeutics, specifically engineered to tackle a range of neuromuscular ailments. The company leverages its proprietary EEV platform to cultivate a rich pipeline of therapeutic programs, integrating oligonucleotide, antibody, and enzyme-based approaches. Its foremost product candidate, ENTR-601-44, is currently undergoing preclinical assessment for its potential in addressing both Duchenne muscular dystrophy and myotonic dystrophy type 1. Furthermore, Entrada is actively developing EEV-PMO-CAG, also targeting myotonic dystrophy type 1. Incorporated in 2016, the firm was formerly known as CycloPorters, Inc., before officially changing its name to Entrada Therapeutics, Inc. in October 2017. The company maintains its corporate headquarters in Boston, Massachusetts.

Key metrics

Market cap

$274.66M

P/E (TTM)

-1.79

EPS (TTM)

$-3.96

Beta

-0.26

Dividend yield

0.00%

Revenue / share

$0.11

50-day avg

$7.07

200-day avg

$9.69

52-week high

$16.45

52-week low

$5.02

CEO

Dipal Doshi

ETFs linked to TRDA

Broad-market and Healthcare sector ETFs an investor holding Entrada Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how TRDA fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze TRDA in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Entrada Therapeutics?: Entrada Therapeutics trades under the ticker TRDA on NASDAQ.
Which exchange is TRDA listed on?: TRDA is listed on NASDAQ.
What sector does Entrada Therapeutics operate in?: Entrada Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze TRDA in a portfolio?: PortView shows TRDA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.